| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/23/1998 | CN1193980A G-protein receptor HTNAD 29 |
| 09/23/1998 | CN1193908A Method for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 09/23/1998 | CN1193907A Preparation and methods for the treatment of T cell mediated diseases |
| 09/23/1998 | CN1193659A IV collagen enzyme specific antibody for human gene engineering |
| 09/22/1998 | US5811535 Human cartilege gp39-like gene |
| 09/22/1998 | US5811524 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 09/22/1998 | US5811518 Polypeptide having specified amino acid sequence, capable of being specifically bound by antibody |
| 09/22/1998 | US5811517 Polynucleotides encoding intercellular adhesion molecule, and variants which display one or more ligand/receptor binding biological activities; cytoplasmic tail variants |
| 09/22/1998 | US5811454 3-fluorobenzamides with nitrogen mustard groups; anticarcinogenic agents |
| 09/22/1998 | US5811262 Hepatocellular carcinoma oncogene |
| 09/22/1998 | US5811238 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 09/22/1998 | US5811237 Sequence coding for protein expressed by campylobacter pylori |
| 09/22/1998 | US5811106 Polypeptides produced by human malaria parasites |
| 09/22/1998 | US5811105 Oral vaccines against strains of salmonella |
| 09/22/1998 | US5811104 Efficacious vaccine against feline infectious peritonitis virus; manipulation to generate an immune response. |
| 09/22/1998 | US5811103 An isolated dna ssequence encoding the ff/f8 kd protein of hcv; recombinant mucleic acid of a vector and the dna sequence; cell cultures |
| 09/22/1998 | US5811102 Modified meningococcal polysaccharide conjugate vaccines |
| 09/22/1998 | US5811100 Hyaluronidase covalently coupled to immunostimulating carrier |
| 09/22/1998 | US5811099 Method and composition for preserving antigens and process for utilizing cytological material produced by same |
| 09/22/1998 | US5811097 Decreasing growth of tumor cells by administering blocking agent which binds to extracellular domain of cytotoxic t-lymphocyte-associated molecule and inhibits signaling |
| 09/22/1998 | US5811075 Method and agents for removing advanced glycosylation endproducts |
| 09/21/1998 | CA2232828A1 Humanized anti-human fas antibody |
| 09/21/1998 | CA2232637A1 Composition containing a compound which directly or indirectly modifies the activity of endogenous t1-m protein |
| 09/21/1998 | CA2200633A1 Rapid production of autologous tumor vaccines |
| 09/19/1998 | CA2224128A1 Cdna clone hnfdy20 that encodes a novel human 7-transmembrane receptor |
| 09/17/1998 | WO1998040738A1 Prostate specific antigen substrates |
| 09/17/1998 | WO1998040497A2 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
| 09/17/1998 | WO1998040493A1 Fiv vaccine |
| 09/17/1998 | WO1998040488A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | WO1998040408A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | WO1998040100A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT |
| 09/17/1998 | WO1998040099A1 Leptospira pathogens |
| 09/17/1998 | WO1998040098A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 09/17/1998 | WO1998040097A2 Bovine respiratory and enteric coronavirus as a vaccine |
| 09/17/1998 | WO1998040065A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | WO1998040049A2 Specific magnetosome, method for the production and use thereof |
| 09/17/1998 | WO1998029565A3 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/17/1998 | WO1998026747A3 Superantigen based methods and compositions for treatment of diseases |
| 09/17/1998 | WO1998007850A3 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 09/17/1998 | DE19708713A1 Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen Using anti-CD44 antibodies containing preparations for the treatment of certain tumors and for the suppression of immune responses |
| 09/17/1998 | CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | CA2284514A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 09/17/1998 | CA2284137A1 Prostate specific antigen substrates |
| 09/17/1998 | CA2283746A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | CA2283624A1 Leptospira pathogens |
| 09/17/1998 | CA2283557A1 Use of nucleic acids containing unmethylated cpg dinucleotide as an adjuvant |
| 09/17/1998 | CA2283490A1 Fiv vaccine |
| 09/17/1998 | CA2283173A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | CA2232119A1 Use of a strain of pasteurella haemolytica serotype a6 for the preparation of a vaccine against bovine pneumonic pasteurellosis due to pasteurella haemolytica |
| 09/16/1998 | EP0864652A1 Expression of a foamy virus envelope protein |
| 09/16/1998 | EP0864649A2 Method for obtaining recombinant surface antigen of hepatitis B virus (HEP B) of higher immunogenic capacity and use thereof in a vaccine preparation |
| 09/16/1998 | EP0864646A2 Process for the inactivation of enveloped viruses |
| 09/16/1998 | EP0864644A1 Non-pathogenic E.Coli mutant strain, process or their preparation and uses |
| 09/16/1998 | EP0864323A1 Pharmaceutical preparation for oral application containing a histamine-immunoglobulin complex |
| 09/16/1998 | EP0863992A1 Product and process to regulate actin polymerization |
| 09/16/1998 | EP0863991A1 Antigenic preparations |
| 09/16/1998 | EP0863986A1 Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
| 09/16/1998 | EP0863981A1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 09/16/1998 | EP0863913A1 A method to increase the density of antigen on antigen presenting cells |
| 09/16/1998 | EP0863704A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 09/16/1998 | EP0706574B1 Methods for peptide synthesis and purification |
| 09/16/1998 | EP0554356B1 A monoclonal antibody |
| 09/16/1998 | EP0530265B1 Dna encoding human 5-ht 1d receptors and uses thereof |
| 09/16/1998 | EP0493575B1 Rotavirus reassortant vaccine |
| 09/16/1998 | EP0485430B1 Methods and compositions for ameliorating the symptoms of sepsis |
| 09/16/1998 | CN1193353A Allergen-XCD32 fusion proteins |
| 09/16/1998 | CN1193352A Human chitinase, its recombinant production, its use for decomposing chitin, and its use in therapy or prophylaxis against infection diseases |
| 09/16/1998 | CN1193351A Method for identifying attenuated chickenpox virous OKA strain or strain originating therein |
| 09/16/1998 | CN1193349A Vaccine for infectious agents, compositions for treating and preventing HIV infections |
| 09/16/1998 | CN1193324A Acellular pertussis vaccines and method of preparation thereof |
| 09/16/1998 | CN1193278A Chemical compounds |
| 09/16/1998 | CN1192929A Oral medicinal preparation |
| 09/15/1998 | US5808033 Family of anti-carcinoembryonic antigen chimeric antibodies |
| 09/15/1998 | US5808024 Nucleic acids encoding high molecular weight major outer membrane protein of moraxella |
| 09/15/1998 | US5808007 Treating cell proliferative or immunologic disorders |
| 09/15/1998 | US5808005 Medical diagnosis; vaccines |
| 09/15/1998 | US5808000 Virus-safe monomeric human immunoglobulin A and methods for its production |
| 09/15/1998 | US5807997 Method for immobilization of thiol compounds via activation of polymers, activated polymers, and products obtained by the method |
| 09/15/1998 | US5807992 Vaccines; medical diagnosis |
| 09/15/1998 | US5807988 Isolation, characterization, and use of the human and subunit of the high affinity receptor for immunoglobulin E |
| 09/15/1998 | US5807979 Genetic engineering; hybrids polypeptides |
| 09/15/1998 | US5807836 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 09/15/1998 | US5807831 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 09/15/1998 | US5807826 Semaphorin gene family |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | US5807757 Controlling particle size distribution |
| 09/15/1998 | US5807746 Administering signal peptide complex; antisense therapy, gene transfer |
| 09/15/1998 | US5807734 Polypeptide |
| 09/15/1998 | US5807723 Homologously recombinant slow growing mycobacteria and uses therefor |
| 09/15/1998 | US5807712 Genetic engineered protein |
| 09/15/1998 | US5807706 Genetic engineering |
| 09/15/1998 | US5807689 Bioanalysis |
| 09/15/1998 | US5807685 Lyme disease |
| 09/15/1998 | US5807559 Compositions for generating T cell immunity against carbohydrate structures |
| 09/15/1998 | US5807557 Vaccine |
| 09/15/1998 | US5807553 Immonogenic oligosaccharide compositions |
| 09/15/1998 | US5807552 Compositions for conferring immunogenicity to a substance and uses thereof |
| 09/15/1998 | US5807550 Antibodies specifically recognizing somatotropin binding proteins |
| 09/15/1998 | US5807534 In vivo binding pair pretargeting |
| 09/14/1998 | CA2221830A1 Tumor necrosis factor related receptor, tr6 |